Peripheral Neuropathy: History and Discovery

Peripheral neuropathy is not one disease but an umbrella term for damage to the nerves that run outside the brain and spinal cord — the wiring that carries sensation from the skin and movement to the muscles. The symptoms it produces — numbness, tingling, burning pain, and weakness in the hands and feet — have been recognized for thousands of years, long before anyone understood that a slender peripheral nerve could be the thing at fault. This page traces how that understanding was assembled: from the ancient nerve damage of leprosy, through the 19th-century microscope work that finally explained how a cut nerve fibre dies, to the great named neuropathies (Charcot-Marie-Tooth in 1886, Guillain-Barré in 1916), the slow recognition of diabetes and vitamin deficiency as causes, and the mid-20th-century invention of nerve conduction studies that let doctors measure nerve damage directly. Throughout, accuracy is paramount: where a date, a discoverer, or a “first” is firmly established it is named; where a claim is interpretation or hypothesis, it is labelled as such.

Table of Contents

  1. An Umbrella Term: What “Peripheral Neuropathy” Means
  2. Ancient Recognition: Leprosy and Numb Limbs
  3. The Words: “Neuropathy,” “Neuritis,” and the Nervous System
  4. The 19th Century: Anatomy, the Microscope, and the Dying Fibre
  5. Charcot, Marie, and Tooth (1886): A Hereditary Neuropathy
  6. Diabetic Neuropathy: From Symptom to Recognized Cause
  7. Beriberi and Vitamin Deficiency: Eijkman and the Antineuritic Factor
  8. Guillain, Barré, and Strohl (1916): The Acute Inflammatory Neuropathy
  9. Measuring the Nerve: Electrodiagnosis in the 20th Century
  10. Research Papers and References
  11. Connections

An Umbrella Term: What “Peripheral Neuropathy” Means

Before the history makes sense, it helps to be clear about the term. Peripheral neuropathy means damage or dysfunction of the peripheral nerves — the nerves that branch out from the spinal cord and brainstem to reach every part of the body. It is a description of a state, not the name of a single illness. A person can arrive at that state by dozens of different roads: diabetes, vitamin deficiency, infection, inherited gene faults, autoimmune attack, toxins, chemotherapy, alcohol, kidney failure, or physical injury. Because the causes are so varied, the history of peripheral neuropathy is really the history of many separate discoveries that were only gradually recognized as belonging to the same family.

It also helps to keep three different kinds of milestone apart, because they are easy to blur. The first is describing a pattern of symptoms — noticing that certain people lose feeling in their feet, or that a family tends to develop high-arched feet and thin lower legs. The second is naming it — attaching an eponym or a disease label so that doctors can talk about the same thing. The third, often arriving much later, is establishing the cause and mechanism — showing why the nerve fails. For most of the neuropathies in this article, description came first, naming followed, and the true cause was understood only decades or even a century afterward.

This page focuses on the broad concept and on a handful of landmark named forms that anchor the history. It is not a catalogue of every neuropathy, and it is a history rather than a treatment guide; for what peripheral neuropathy is today, how it is diagnosed, and how it is managed, see the main Peripheral Neuropathy page.

Back to Table of Contents

Ancient Recognition: Leprosy and Numb Limbs

The experience of nerve damage is ancient, even though the explanation is modern. Numbness, pins-and-needles, burning pain, and weak, wasting limbs are described in some of the oldest medical writings, and the single most important ancient example is leprosy. Skeletal evidence consistent with leprosy has been reported from India dating to roughly 2000 BCE, and the disease is referred to in ancient Sanskrit and other early texts. Crucially, much of leprosy’s devastation is neuropathic: the bacterium that causes it attacks the nerves of the skin and limbs, so that affected people lose sensation, injure themselves without feeling it, and develop the deformities and damage that made the disease so feared. To the modern eye, classical leprosy is in large part a profound peripheral neuropathy — and it remains one of the most common causes of non-traumatic peripheral nerve damage in the world today.

The cause of leprosy was identified far later. In 1873 the Norwegian physician Gerhard Armauer Hansen observed rod-shaped microbes in tissue from leprosy patients — the organism now called Mycobacterium leprae — the first bacterium shown to cause a human disease. Later work established that the organism has a particular affinity for the Schwann cells that wrap and insulate peripheral nerve fibres, which is precisely why the disease produces such striking loss of feeling and muscle wasting. The ancient observers could see the numb, damaged limbs; only the nineteenth and twentieth centuries could explain that an infection of the nerves themselves was responsible.

Leprosy is the clearest ancient thread, but it is not the only one. Physicians across many early traditions recorded the symptoms we would now group as neuropathic — loss of sensation, weakness, and wasting — without a framework that singled out the peripheral nerve as the culprit. The recognition that a tingling foot and a withered calf could both trace back to damaged peripheral nerves required an anatomy of the nervous system that did not yet exist.

Back to Table of Contents

The Words: “Neuropathy,” “Neuritis,” and the Nervous System

The vocabulary of nerve disease is itself a piece of history. The word neuropathy is built from the Greek neuron (“nerve,” originally “sinew” or “cord”) and the suffix -pathy (from pathos, “suffering” or “disease”) — literally “nerve suffering” or “disease of the nerves.” That root etymology is well established. The closely related term neuritis — the -itis ending implies inflammation — was widely used in the nineteenth and early twentieth centuries for what we would now often call neuropathy, on the then-common assumption that nerve disease meant nerve inflammation; many older sources speak of “peripheral neuritis” or “polyneuritis” where a modern textbook would say polyneuropathy.

The eighteenth century supplied a foundational, if broader, label for diseases of the nervous system. The Scottish physician William Cullen (1710–1790) is credited with coining the term neurosis in his 1769 nosology (Synopsis Nosologiae Methodicae), where it denoted a wide class of nervous-system disorders — affections of sensation and movement — that occurred without fever and without an obvious local lesion. Cullen’s “neurosis” is not the same as our “neuropathy,” and it would later drift toward its modern psychological meaning; the point of historical accuracy is that Cullen named a broad category of nervous disease, and the available sources credit him specifically with neurosis, not with coining neuropathy. The narrowing of focus onto the peripheral nerve as a distinct site of disease was the achievement of the next century.

Across the nineteenth and twentieth centuries the terminology gradually sharpened. As microscopy and electrophysiology showed that many “neuritides” involved degeneration rather than true inflammation, the more neutral term neuropathy increasingly replaced neuritis, and qualifiers multiplied: mononeuropathy (one nerve), polyneuropathy (many nerves, usually symmetrical), sensory, motor, and autonomic neuropathy. This shifting vocabulary is worth keeping in mind when reading older medical literature, where the same condition may appear under several different names.

Back to Table of Contents

The 19th Century: Anatomy, the Microscope, and the Dying Fibre

The decisive turn in understanding peripheral neuropathy came not from the bedside but from the laboratory bench, as nineteenth-century anatomy and improving microscopes finally revealed what a nerve actually is and how it dies. The landmark experiment belongs to the British physiologist Augustus Volney Waller (1816–1870). In work read to the Royal Society in 1849 and published in its Philosophical Transactions in 1850, Waller cut the glossopharyngeal and hypoglossal nerves of frogs and then watched, under the microscope, what happened to the fibres downstream of the cut. He found that the portion of the nerve separated from its parent cell body broke down — the fatty insulation curdling and fragmenting — while the portion still connected to the cell body survived.

From this Waller drew an inference of lasting importance: that the nerve cell body nourishes its fibre, and that a fibre severed from its cell is doomed to degenerate. This process of orderly breakdown of the distal nerve is now called Wallerian degeneration in his honour, and it is foundational to the whole concept of peripheral neuropathy — it explains, at the level of the single fibre, what “nerve damage” physically means and why injury to a nerve produces loss downstream of the injury. Waller’s technique also became a practical tool for tracing nerve pathways, and his observations are often described as a starting point for the neuron theory that would mature later in the century.

Waller’s work sat within a wider nineteenth-century flowering of neuroanatomy and neuropathology. Improved staining and microscopy allowed investigators across Europe to distinguish axons from their myelin sheaths, to identify the Schwann cells that wrap peripheral fibres, and to recognize different patterns of nerve degeneration. This is the period in which the peripheral nerve became a defined object of study rather than an undifferentiated “sinew,” and it set the stage for clinicians to begin matching specific patterns of weakness and numbness to specific diseases of those nerves — the achievement that produced the great named neuropathies of the 1880s onward.

Back to Table of Contents

Charcot, Marie, and Tooth (1886): A Hereditary Neuropathy

The year 1886 is a landmark in the history of peripheral neuropathy because it produced the first clear clinical descriptions of a distinct inherited nerve disease, arrived at independently on two sides of the English Channel. In France, the eminent neurologist Jean-Martin Charcot (1825–1893) and his pupil Pierre Marie (1853–1940) published a series of patients with a characteristic pattern: progressive wasting and weakness that began in the small muscles of the feet and lower legs, producing the foot deformities and “stork leg” appearance that would become the disease’s signature. They described it in terms of peroneal muscular atrophy, after the peroneal (lower-leg) muscles first affected.

In the same year, in England, Howard Henry Tooth (1856–1926) described the same disorder in his Cambridge medical dissertation, also using the term peroneal progressive muscular atrophy. Tooth’s contribution carried a particularly important insight: he argued that the disorder was fundamentally a disease of the nerves (a neuropathy) rather than of the spinal cord or the muscles themselves, as some contemporaries believed. Combining the three names, the condition became known as Charcot-Marie-Tooth disease (CMT), and it is also called hereditary motor and sensory neuropathy. It is fair, and accurate, to note that earlier physicians had reported similar cases before 1886; the achievement of Charcot, Marie, and Tooth was to define the pattern clearly and (in Tooth’s case) to locate the fault in the peripheral nerve.

Charcot-Marie-Tooth disease matters to this history for two reasons. First, it established that a peripheral neuropathy could be inherited — a constitutional, lifelong condition rather than the result of an external poison or infection. Second, the underlying causes were worked out only much later: across the late twentieth century, genetic research showed that CMT is not one disease but a large group of disorders caused by mutations in genes governing the myelin sheath and the axon of peripheral nerves. The 1886 description named the clinical picture; the molecular explanation — faulty peripheral-nerve proteins — took another hundred years.

Back to Table of Contents

Diabetic Neuropathy: From Symptom to Recognized Cause

Today, diabetes is the single commonest cause of peripheral neuropathy in much of the world, but the link between high blood sugar and nerve damage had to be argued into existence. That the two travelled together had been noticed for a long time, yet it was genuinely unclear which was cause and which was effect — some physicians supposed the nervous disturbance might somehow produce the diabetes. The pivotal reframing is credited to the French physician Charles-Jacob Marchal de Calvi (1815–1873). In his 1864 work Recherches sur les accidents diabétiques (“Research on diabetic complications”), he marshalled the argument that the nerve damage and other vascular complications were a consequence of long-standing diabetes, not its cause — observing, for example, the pains and patches of numbness in the limbs of diabetic patients and reasoning that the disease was injuring the nerves.

This was a conceptual milestone rather than a mechanistic one. Marchal de Calvi did not have the tools to show how diabetes harms nerves; what he established was the direction of cause and effect — that prolonged diabetes can damage the peripheral nervous system. Through the later nineteenth and into the twentieth century, clinicians steadily filled in the clinical picture of diabetic neuropathy: the symmetrical “glove and stocking” loss of sensation beginning in the feet, the burning pains, the loss of reflexes, and the insensitive foot that is so vulnerable to unnoticed injury and ulceration.

The deeper mechanisms — how chronically high glucose injures nerves through metabolic and microvascular pathways — were the work of the twentieth and twenty-first centuries and remain an active research field. For the history of the concept, the essential step is the nineteenth-century recognition, anchored to Marchal de Calvi’s 1864 argument, that diabetes is a cause of peripheral neuropathy. The detail of diabetic nerve disease today is covered on the site’s Diabetes page.

Back to Table of Contents

Beriberi and Vitamin Deficiency: Eijkman and the Antineuritic Factor

A second great cause of peripheral neuropathy — deficiency — entered medicine through the disease beriberi. Beriberi, long endemic in rice-eating regions of Asia, produces (in its “dry” form) a severe symmetrical peripheral neuropathy: weakness, wasting, numbness, and burning pain in the legs, with loss of reflexes. For most of history it was assumed to be an infection or a poison. The turning point came in the Dutch East Indies (now Indonesia), where the physician Christiaan Eijkman (1858–1930) was investigating beriberi at a laboratory in Batavia (modern Jakarta).

Around 1890, Eijkman noticed that laboratory chickens fed largely on polished (white) rice developed a nerve disease — a polyneuritis — resembling human beriberi, and that the illness could be prevented or reversed by feeding them the discarded rice husks and bran (or unpolished rice). By 1897 he reported this striking dietary effect, and supporting observations among prison populations showed far lower beriberi rates where unpolished rice was eaten. This was powerful evidence that something removed from rice during polishing was protective — the first strong experimental link between a specific dietary lack and a peripheral neuropathy.

Historical accuracy requires an important caveat about interpretation. Eijkman himself initially clung to the idea that polished rice contained, or allowed, a toxin, rather than that it lacked an essential nutrient. It was his successor Gerrit Grijns who, around 1901, argued the modern interpretation: that beriberi is a deficiency disease, caused by the absence of an essential substance in the rice bran. That substance was later identified as thiamine (vitamin B1), and the broader idea of “accessory food factors” or vitamins grew from this line of work. Eijkman shared the 1929 Nobel Prize in Physiology or Medicine (with Frederick Gowland Hopkins) for the discovery of the antineuritic vitamin. So while Eijkman’s experiments were the crucial breakthrough that beriberi neuropathy is caused by something in the diet, the correct deficiency interpretation is properly shared with Grijns — a nuance often flattened in popular accounts. The vitamin-B1 story is told on the site’s Thiamine and Beriberi page, and other nutritional neuropathies, including B12 deficiency, on the Vitamin B12 page.

Back to Table of Contents

Guillain, Barré, and Strohl (1916): The Acute Inflammatory Neuropathy

If Charcot-Marie-Tooth is the archetypal inherited, slowly progressive neuropathy, the disease described in 1916 is the archetypal acute, post-infectious one. During the First World War, three French physicians — Georges Guillain (1876–1961), Jean Alexandre Barré (1880–1967), and André Strohl (1887–1977) — reported two soldiers who developed a rapidly ascending paralysis with loss of reflexes, followed by recovery. Their published account described a syndrome of motor weakness and areflexia with a distinctive laboratory finding in the spinal fluid.

That finding — albumino-cytological dissociation — is the heart of the paper’s lasting importance: the cerebrospinal fluid showed a raised protein level but a normal cell count, a pattern that helped distinguish the condition from poliomyelitis, which was then epidemic and which raises the cell count. Strohl, the most often forgotten of the three, contributed the electrophysiological observations — recordings of the patients’ reflexes — an early use of the kind of bedside electrical testing that would later become central to diagnosing neuropathy. The condition became known as Guillain-Barré syndrome (the eponym frequently, and somewhat unfairly, drops Strohl’s name), and it is understood today as an acute inflammatory polyradiculoneuropathy — an autoimmune attack on the peripheral nerves, often triggered by a preceding infection.

Guillain-Barré syndrome rounds out the historical picture by adding the category of immune-mediated peripheral neuropathy. Between them, the leprosy thread (infection), the Charcot-Marie-Tooth thread (inheritance), the diabetic and beriberi threads (metabolic and nutritional), and the Guillain-Barré thread (autoimmune) capture the major mechanisms by which peripheral nerves come to grief — the diversity that makes “peripheral neuropathy” an umbrella rather than a single diagnosis.

Back to Table of Contents

Measuring the Nerve: Electrodiagnosis in the 20th Century

For all the clinical insight of the nineteenth century, doctors could only infer nerve damage from a patient’s symptoms and examination. The twentieth century gave them a way to measure it directly, and this is the final essential thread in the history of peripheral neuropathy. The key technique is the nerve conduction study: a nerve is stimulated with a small electrical pulse at one point and the response is recorded farther along, allowing the speed and size of the nerve signal to be quantified. A slowed signal points toward damage of the insulating myelin; a shrunken signal points toward loss of the nerve fibres (axons) themselves.

The foundational work clustered around the end of the Second World War and the years just after. In the United States, Hodes, Larrabee, and German published in 1948 a landmark study measuring the conduction velocity of motor nerves in human subjects by stimulating the nerve and recording the muscle’s combined electrical response (what is now called the compound muscle action potential). In Britain, George Dawson, in work of the late 1940s and around 1950, pioneered the recording of sensory nerve action potentials through the skin. Together these advances created the practical toolkit of modern electrodiagnosis — nerve conduction studies and electromyography — which from the mid-twentieth century allowed clinicians to confirm a peripheral neuropathy, localize it, gauge its severity, and begin to classify it as primarily demyelinating or axonal.

It is worth appreciating how this closed a loop opened a century earlier. Waller had shown in 1850, under the microscope, that a damaged nerve fibre degenerates; electrodiagnosis let physicians detect the functional signature of exactly that degeneration in a living patient, without a microscope and without surgery. With anatomy, named clinical syndromes, identified causes, and now a measuring instrument, the disparate threads of two thousand years finally converged into the coherent modern concept of peripheral neuropathy — an umbrella diagnosis with many causes, recognizable patterns, and, increasingly, specific treatments.

Back to Table of Contents

Research Papers and References

The list below combines key peer-reviewed historical reviews with curated PubMed topic-search links into the literature on the people and discoveries described above. Historical primary texts (Waller’s 1850 Philosophical Transactions paper; the 1886 reports of Charcot & Marie and of Tooth; Marchal de Calvi’s 1864 Recherches; the 1916 paper of Guillain, Barré, and Strohl) are named in the article as historical sources. Where a reliable DOI or PMID is available it is given; otherwise a PubMed topic search is provided. Links open in a new tab.

  1. Walusinski O. Charles-Jacob Marchal de Calvi (1815-1873), description of arteriopathy and diabetic neuropathy. Rev Neurol (Paris). 2023;179(9):955-960. — doi:10.1016/j.neurol.2023.03.025
  2. Waclawik AJ. The Legacy of the Seminal Publication by Guillain, Barré, and Strohl: The History Behind the Eponym. WMJ. 2018;117(4):160-163. — PMID: 30407766
  3. Stoll G, Müller HW. Degeneration and regeneration of the peripheral nervous system: from Augustus Waller’s observations to neuroinflammation. J Peripher Nerv Syst. 2002;7(1):13-27. — doi:10.1046/j.1529-8027.2002.02002.x
  4. Pareyson D, Marchesi C. Charcot-Marie-Tooth disease and related neuropathies (history and classification) — PubMed: Charcot-Marie-Tooth history
  5. Augustus Volney Waller and Wallerian degeneration — history and clinical significance — PubMed: Wallerian degeneration history
  6. Guillain-Barré syndrome — centenary and history of the 1916 description — PubMed: Guillain-Barré syndrome history
  7. Christiaan Eijkman, Gerrit Grijns, beriberi and the antineuritic vitamin — PubMed: Eijkman, beriberi and thiamine history
  8. History of diabetic neuropathy — from clinical recognition to mechanism — PubMed: diabetic neuropathy history
  9. Leprosy (Hansen’s disease), Mycobacterium leprae, Schwann cells and peripheral nerve damage — PubMed: leprosy and peripheral nerve damage
  10. History of nerve conduction studies and electrodiagnosis (Hodes, Larrabee, German; Dawson) — PubMed: history of nerve conduction studies
  11. William Cullen and the earliest medical use of the term “neurosis” — PubMed: Cullen and the term neurosis
  12. Peripheral neuropathy — classification, causes, and evaluation (overview) — PubMed: peripheral neuropathy overview

External Authoritative Resources

Back to Table of Contents

Connections

Back to Table of Contents